Abstract
Objective: Thirty-six months of isoniazid preventive therapy (36IPT) was superior to 6 months of IPT (6IPT) in preventing tuberculosis (TB) among HIV-infected adults in Botswana. We assessed the posttrial durability of this benefit.
Original language | English (US) |
---|---|
Pages (from-to) | 351-359 |
Number of pages | 9 |
Journal | AIDS |
Volume | 29 |
Issue number | 3 |
DOIs | |
State | Published - Feb 1 2015 |
Externally published | Yes |
Keywords
- Antiretroviral therapy
- HIV
- Isoniazid
- Preventive therapy
- Tuberculin
- Tuberculosis
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases
- General Medicine